In a 29-year-old male presenting with anxiety and tachycardia after binge drinking, with a history of recurrent similar episodes and no red‑flag cardiac symptoms, should I start escitalopram (Lexapro) or refer him to cardiology?

Do Not Start Lexapro—Address the Underlying Pattern First

This patient needs immediate psychiatric referral and alcohol use disorder assessment, not empiric SSRI initiation. Starting escitalopram 5mg now would be premature and potentially harmful without first ruling out cardiac pathology and addressing his recurrent alcohol-related presentations.

Why Not Start Lexapro Right Now

The Cardiac Risk Assessment Must Come First

The European Heart Journal guideline 1 provides a clear algorithm: before starting any psychotropic medication with pro-arrhythmic potential (escitalopram is Class B), you must:

• Obtain a baseline ECG to assess for QT prolongation, conduction disorders, or structural heart disease
• Take a focused cardiac history specifically asking about chest pain, dyspnea, palpitations, syncope/near-syncope, and family history of sudden cardiac death
• Review all medications for drug interactions and other QT-prolonging agents

You cannot skip this step. The FDA label 2 explicitly warns that Lexapro overdose can cause "QRS and QTc interval prolongation, wide complex tachyarrhythmias, and torsade de pointes" and that "prolonged cardiac monitoring is recommended" in overdose situations. While therapeutic dosing is different, recent research 3 shows that 20% of patients >65 years reach potentially pro-arrhythmic concentrations even on 10mg escitalopram—and this patient's recurrent alcohol binges create additional cardiac risk 4.

The Alcohol Pattern Is the Real Problem

This 29-year-old has a recurrent pattern of binge drinking (8 beers) followed by anxiety and tachycardia, leading to repeated urgent care/ER visits. This is not generalized anxiety disorder—this is:

1. Alcohol withdrawal physiology (sympathetic hyperactivity causing tachycardia and anxiety)
2. Panic about the physical symptoms (health anxiety)
3. Avoidance of psychiatric follow-up (suggesting poor insight or ambivalence about treatment)

Starting an SSRI treats none of these root causes and may give false reassurance that the problem is being addressed.

What You Should Do Instead

Step 1: Rule Out Cardiac Pathology (Today)

• Get an ECG now before he leaves urgent care
• Measure QTc interval (if >500ms or >60ms above baseline, cardiology referral is mandatory 1)
• Check electrolytes (alcohol causes hypokalemia/hypomagnesemia, which increase arrhythmia risk)
• Ask specifically: any chest pain, syncope, or family history of sudden death under age 40?

If ECG is normal and no red flags: cardiac etiology is unlikely, and cardiology referral is not needed.

If ECG shows QTc prolongation or other abnormalities: refer to cardiology before starting any psychotropic medication 1.

Step 2: Address the Alcohol Use Disorder (Today)

• Use AUDIT-C or single-question screening: "How many times in the past year have you had 5+ drinks in a day?"
• 8 beers in one night = binge drinking by definition
• Explain that his symptoms (racing heart, anxiety) are expected physiologic responses to alcohol withdrawal, not a primary anxiety disorder
• Discuss that SSRIs won't prevent these episodes if he continues binge drinking

Step 3: Mandate Psychiatric Follow-Up (Within 1 Week)

Do not start escitalopram without psychiatric evaluation. Here's why:

• His repeated pattern of seeking acute care but refusing follow-up suggests either poor insight, untreated substance use disorder, or health anxiety that needs specialized assessment
• The FDA label 2 notes that Lexapro "has not been systematically evaluated in patients with a recent history of myocardial infarction or unstable heart disease" and requires caution in patients with altered hemodynamic responses
• If he does have a primary anxiety disorder, it needs proper diagnosis and comprehensive treatment planning—not a 5mg trial from urgent care

Provide a specific psychiatric referral (name, phone number, appointment time if possible) and document that you explained the importance of follow-up.

Step 4: Bridge Management (Next 1-7 Days)

For immediate symptom relief while awaiting psychiatric evaluation:

• Propranolol 10-20mg as needed for palpitations/physical anxiety symptoms (if no contraindications on ECG)
• Avoid alcohol (give specific harm reduction advice: if he drinks again, taper rather than abrupt cessation)
• Sleep hygiene and hydration counseling
• Return precautions: chest pain, syncope, worsening symptoms

Common Pitfalls to Avoid

1. Don't treat the symptom without addressing the cause. His anxiety is likely secondary to alcohol withdrawal, not a primary disorder requiring chronic SSRI therapy.

2. Don't start SSRIs without baseline ECG in patients with cardiac symptoms. Research shows escitalopram causes pro-arrhythmic changes at therapeutic concentrations 3, and citalopram (the racemic form) increases ventricular arrhythmia risk in older adults 5. While he's young, his binge drinking adds cardiac risk 4.

3. Don't enable the pattern of acute visits without follow-up. By starting medication without requiring psychiatric evaluation, you reinforce his avoidance of comprehensive care.

4. Don't assume 5mg is "safe enough." The FDA label 2 shows escitalopram has dose-dependent effects, but even low doses require proper monitoring, especially with concomitant alcohol use.

If He Refuses Psychiatric Referral

Document thoroughly that you:

• Explained the need for comprehensive psychiatric evaluation
• Discussed the risks of untreated alcohol use disorder
• Offered specific referral resources
• Advised against starting SSRI without proper workup

Do not prescribe escitalopram just because he's asking for it or to "do something." The guideline 1 is clear: if cardiac risk factors are present or assessment is incomplete, either optimize those factors first or choose a medication with more favorable cardiac profile—but in this case, the primary issue isn't medication choice, it's getting him into appropriate longitudinal care.